The impact of TP53 activation and apoptosis in primary hereditary microcephaly

被引:7
作者
Iegiani, Giorgia [1 ,2 ]
Ferraro, Alessia [1 ,2 ]
Pallavicini, Gianmarco [1 ,2 ]
Di Cunto, Ferdinando [1 ,2 ]
机构
[1] Univ Turin, Dept Neurosci Rita Levi Montalcini, Turin, Italy
[2] Neurosci Inst Cavalieri Ottolenghi, Turin, Italy
关键词
neurodevelopment; microcephaly; DNA damage; TP53; cell death; asymmetric division; mitosis; neural precursor; DNA-DAMAGE RESPONSE; CELL FATE DECISIONS; NEURAL STEM-CELLS; CITRON KINASE; DEFECTIVE NEUROGENESIS; PROGENITOR CELLS; RADIAL GLIA; LAMIN B1; PROTEIN; MOUSE;
D O I
10.3389/fnins.2023.1220010
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Autosomal recessive primary microcephaly (MCPH) is a constellation of disorders that share significant brain size reduction and mild to moderate intellectual disability, which may be accompanied by a large variety of more invalidating clinical signs. Extensive neural progenitor cells (NPC) proliferation and differentiation are essential to determine brain final size. Accordingly, the 30 MCPH loci mapped so far (MCPH1-MCPH30) encode for proteins involved in microtubule and spindle organization, centriole biogenesis, nuclear envelope, DNA replication and repair, underscoring that a wide variety of cellular processes is required for sustaining NPC expansion during development. Current models propose that altered balance between symmetric and asymmetric division, as well as premature differentiation, are the main mechanisms leading to MCPH. Although studies of cellular alterations in microcephaly models have constantly shown the co-existence of high DNA damage and apoptosis levels, these mechanisms are less considered as primary factors. In this review we highlight how the molecular and cellular events produced by mutation of the majority of MCPH genes may converge on apoptotic death of NPCs and neurons, via TP53 activation. We propose that these mechanisms should be more carefully considered in the alterations of the sophisticated equilibrium between proliferation, differentiation and death produced by MCPH gene mutations. In consideration of the potential druggability of cell apoptotic pathways, a better understanding of their role in MCPH may significantly facilitate the development of translational approaches.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] TP53 family members and human cancers
    Bénard, J
    Douc-Rasy, S
    Ahomadegbe, JC
    HUMAN MUTATION, 2003, 21 (03) : 182 - 191
  • [22] TP53 Mutations in Canine Brain Tumors
    York, D.
    Higgins, R. J.
    LeCouteur, R. A.
    Wolfe, A. N.
    Grahn, R.
    Olby, N.
    Campbell, M.
    Dickinson, P. J.
    VETERINARY PATHOLOGY, 2012, 49 (05) : 796 - 801
  • [23] Utility of TP53 in Breast Carcinoma Immunophenotypes
    Jaggi, Ria
    Shukla, Samarth
    Acharya, Sourya
    Vagha, Sunita
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2020, 14 (09)
  • [24] TP53: a key gene in human cancer
    Guimaraes, DP
    Hainaut, P
    BIOCHIMIE, 2002, 84 (01) : 83 - 93
  • [25] The TP53 signaling network in mammals and worms
    Jolliffe, A. Kristine
    Derry, W. Brent
    BRIEFINGS IN FUNCTIONAL GENOMICS, 2013, 12 (02) : 129 - 141
  • [26] p53 Expression in Luminal Breast Cancer Correlates With TP53 Mutation and Primary Endocrine Resistance
    Mueller, Sophie
    Grote, Isabel
    Bartels, Stephan
    Kandt, Leonie
    Christgen, Henriette
    Lehmann, Ulrich
    Gluz, Oleg
    Graeser, Monika
    Kates, Ron
    Harbeck, Nadia
    Kreipe, Hans
    Christgen, Matthias
    MODERN PATHOLOGY, 2023, 36 (04)
  • [27] Mutational processes shape the landscape of TP53 mutations in human cancer
    Giacomelli, Andrew O.
    Yang, Xiaoping
    Lintner, Robert E.
    McFarland, James M.
    Duby, Marc
    Kim, Jaegil
    Howard, Thomas P.
    Takeda, David Y.
    Ly, Seav Huong
    Kim, Eejung
    Gannon, Hugh S.
    Hurhula, Brian
    Sharpe, Ted
    Goodale, Amy
    Fritchman, Briana
    Steelman, Scott
    Vazquez, Francisca
    Tsherniak, Aviad
    Aguirre, Andrew J.
    Doench, John G.
    Piccioni, Federica
    Roberts, Charles W. M.
    Meyerson, Matthew
    Getz, Gad
    Johannessen, Cory M.
    Root, David E.
    Hahn, William C.
    NATURE GENETICS, 2018, 50 (10) : 1381 - +
  • [28] Citron Kinase Deficiency Leads to Chromosomal Instability and TP53-Sensitive Microcephaly
    Bianchi, Federico Tommaso
    Tocco, Chiara
    Pallavicini, Gianmarco
    Liu, Yifan
    Verni, Fiammetta
    Merigliano, Chiara
    Bonaccorsi, Silvia
    El-Assawy, Nadia
    Priano, Lorenzo
    Gai, Marta
    Berto, Gaia Elena
    Chiotto, Alessandra Maria Adelaide
    Sgro, Francesco
    Caramello, Alessia
    Tasca, Laura
    Ala, Ugo
    Neri, Francesco
    Oliviero, Salvatore
    Mauro, Alessandro
    Geley, Stephan
    Gatti, Maurizio
    Di Cunto, Ferdinando
    CELL REPORTS, 2017, 18 (07): : 1674 - 1686
  • [29] Association of TP53 Polymorphisms with Primary Open-Angle Glaucoma: A Meta-Analysis
    Guo, Yatu
    Zhang, Hongtuan
    Chen, Xia
    Yang, Xiong
    Cheng, Wenbo
    Zhao, Kanxing
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2012, 53 (07) : 3756 - 3763
  • [30] Mutant TP53 Posttranslational Modifications: Challenges and Opportunities
    Nguyen, Thuy-Ai
    Menendez, Daniel
    Resnick, Michael A.
    Anderson, Carl W.
    HUMAN MUTATION, 2014, 35 (06) : 738 - 755